Vivesto AB
F:OMAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vivesto AB
F:OMAX
|
SE |
|
L
|
LEG Immobilien SE
F:LEG
|
DE |
|
P
|
Peabody Energy Corp
F:PBE
|
US |
|
A
|
ACS Actividades de Construccion y Servicios SA
XMUN:OCI1
|
ES |
|
M
|
Masco Corp
DUS:MSQ
|
US |
|
O
|
Orlen SA
XMUN:PKY1
|
PL |
|
A
|
Abb Ltd
XBER:ABJA
|
CH |
|
B
|
Bank of America Corp
SWB:NCB
|
US |
|
N
|
Novo Nordisk A/S
XHAM:NOV
|
DK |
|
S
|
Swatch Group AG
XMUN:UHR
|
CH |
|
F
|
Fastly Inc
LSE:0A3P
|
US |
|
C
|
Cerence Inc
F:0S6
|
US |
|
A
|
Alamo Group Inc
F:AL3
|
US |
|
A
|
Andersons Inc
SWB:AKG
|
US |
|
P
|
Pershing Square Inc
NYSE:PS
|
US |
|
C
|
Chorus Ltd
OTC:CHRUF
|
NZ |
|
A
|
Asahi Kasei Corp
DUS:ASAA
|
JP |
|
U
|
Unity Software Inc
F:US3
|
US |
|
H
|
Home Depot Inc
XMUN:HDI
|
US |
|
Leonteq AG
SIX:LEON
|
CH |
|
T
|
TOTO Ltd
OTC:TOTDF
|
JP |
Bankruptcy Probability
Vivesto AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vivesto AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
Vivesto AB
STO:VIVE
|
88.6m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
356.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
57.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vivesto AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vivesto AB has no debt.
You can find a full breakdown on its Balance Sheet.
